Skip to content
10-Q

Quarterly Report

CORTRONIX BIOMEDICAL ADVANCEMENT TECHNOLOGIES INC.

0001524777-13-000306

← back to feed
Filed
Jul 22, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Jul 19, 2013 287M sh
Operating Cash Flow Q3 2013 · May 31, 2013 −$292.91K
Stockholders Equity Q3 2013 · May 31, 2013 −$943.85K
Stockholders Equity Q3 2013 · Aug 31, 2012 −$10.19K
Stockholders Equity Q3 2013 · Aug 2, 2012 $0
Current Liabilities Q3 2013 · May 31, 2013 $1.03M
Current Liabilities Q3 2013 · Aug 31, 2012 $53.77K
Current Assets Q3 2013 · May 31, 2013 $67K
Current Assets Q3 2013 · Aug 31, 2012 $33.5K
Total Assets Q3 2013 · May 31, 2013 $90.34K
Total Assets Q3 2013 · Aug 31, 2012 $43.58K
Sga Expense Q3 2013 · May 31, 2013 $83.08K
Net Income Q3 2013 · May 31, 2013 −$342.15K
Net Income Q3 2013 · Aug 31, 2012 −$10.94K
Operating Income Q3 2013 · May 31, 2013 −$288.24K